Treatment groups | Doses (mg/kg) | Phase I antioxidant enzymes | Phase II antioxidant enzymes | |||
---|---|---|---|---|---|---|
Catalase U/min | PODc U/min | SODd U/min | GSTe (nM/min/mg protein) | GSRf(μg/mg protein) | ||
Naïve | – | 5.75 ± 0.28b | 6.72 ± 0.36b | 5.65 ± 0.22b | 22.62 ± 1.21b | 138.44 ± 3.45b |
Control | – | 2.32 ± 0.21 | 3.10 ± 0.23 | 1.85 ± 0.16 | 10.58 ± 0.35 | 71.25 ± 2.57 |
APHMg | 100 | 3.25 ± 0.25 | 4.65 ± 0.35 | 3.12 ± 0.15a | 20.25 ± 1.00b | 109.20 ± 2.17a |
APHM | 200 | 4.50 ± 0.22a | 5.95 ± 0.23a | 4.95 ± 0.44b | 21.11 ± 1.10b | 127.25 ± 2.55b |
APHM | 300 | 5.78 ± 0.41b | 6.68 ± 0.1ba | 5.56 ± 0.52b | 21.82 ± 1.16b | 139.12 ± 1.82b |
Silymarin | 100 | 5.65 ± 0.11b | 5.70 ± 0.45b | 5.22 ± 0.33b | 21.45 ± 1.15b | 131.21 ± 2.65b |